|
| 36272172 | Detection of constitutional mismatch repair deficiency in children and adolescents with acute lymphoblastic leukemia. | Leuk Lymphoma | 2023 |
| 35771186 | Documentation and diagnosis of delirium in Parkinson's disease. | Acta Psychiatr Scand | 2023 |
| 35485491 | Free-water imaging of the cholinergic basal forebrain and pedunculopontine nucleus in Parkinson's disease. | Brain | 2023 |
| 37181409 | Mortality by age, gene and gender in carriers of pathogenic mismatch repair gene variants receiving surveillance for early cancer diagnosis and treatment: a report from the prospective Lynch syndrome database. | EClinicalMedicine | 2023 |
| 37143941 | Mismatch repair deficiency testing in Lynch syndrome-associated urothelial tumors. | Front Oncol | 2023 |
| 37441886 | Predicting cognitive decline using neuropsychiatric symptoms in prodromal Lewy body dementia: A longitudinal study. | Parkinsonism Relat Disord | 2023 |
| 36975168 | Progression of atypical parkinsonian syndromes: PROSPECT-M-UK study implications for clinical trials. | Brain | 2023 |
| 37269181 | Network connectivity and structural correlates of survival in progressive supranuclear palsy and corticobasal syndrome. | Hum Brain Mapp | 2023 |
| 37031776 | Sebaceous carcinoma epidemiology, associated malignancies and Lynch/Muir-Torre syndrome screening in England from 2008 to 2018. | J Am Acad Dermatol | 2023 |
| 36586540 | Constitutional Microsatellite Instability, Genotype, and Phenotype Correlations in Constitutional Mismatch Repair Deficiency. | Gastroenterology | 2023 |
| 36572524 | Germline mismatch repair (MMR) gene analyses from English NHS regional molecular genomics laboratories 1996-2020: development of a national resource of patient-level genomics laboratory records. | J Med Genet | 2023 |
| 36597730 | CAPP2 RCT: Resistant Starch Planned Long-term Follow-up-Reply. | Cancer Prev Res (Phila) | 2023 |
| 36214792 | Is HLA type a possible cancer risk modifier in Lynch syndrome? | Int J Cancer | 2023 |
| 34842195 | Evaluation of Bedside Tests of Attention and Arousal Assessing Delirium in Parkinson's Disease, Dementia, and Older Adults. | J Parkinsons Dis | 2022 |
| 35582313 | Level I PD-MCI Using Global Cognitive Tests and the Risk for Parkinson's Disease Dementia. | Mov Disord Clin Pract | 2022 |
| 35732412 | Genetics of validated Parkinson's disease subtypes in the Oxford Discovery and Tracking Parkinson's cohorts. | J Neurol Neurosurg Psychiatry | 2022 |
| 35903017 | Neurofilament light levels predict clinical progression and death in multiple system atrophy. | Brain | 2022 |
| 35954501 | Detection of Microsatellite Instability in Colonoscopic Biopsies and Postal Urine Samples from Lynch Syndrome Cancer Patients Using a Multiplex PCR Assay. | Cancers (Basel) | 2022 |
| 35878732 | Cancer Prevention with Resistant Starch in Lynch Syndrome Patients in the CAPP2-Randomized Placebo Controlled Trial: Planned 10-Year Follow-up. | Cancer Prev Res (Phila) | 2022 |
| 35285068 | Gait-Related Metabolic Covariance Networks at Rest in Parkinson's Disease. | Mov Disord | 2022 |
| 34863788 | The Different Immune Profiles of Normal Colonic Mucosa in Cancer-Free Lynch Syndrome Carriers and Lynch Syndrome Colorectal Cancer Patients. | Gastroenterology | 2022 |
| 35165920 | Neuromelanin-MRI to Quantify and Track Nigral Depigmentation in Parkinson's Disease: A Multicenter Longitudinal Study Using Template-Based Standardized Analysis. | Mov Disord | 2022 |
| 35322414 | Response to 'Cutaneous squamous cell carcinoma is associated with Lynch syndrome: widening the spectrum of Lynch syndrome-associated tumours'. | Br J Dermatol | 2022 |
| 32464705 | Neuropathological and biochemical investigation of Hereditary Ferritinopathy cases with ferritin light chain mutation: Prominent protein aggregation in the absence of major mitochondrial or oxidative stress. | Neuropathol Appl Neurobiol | 2021 |
| 33743481 | Uptake of hysterectomy and bilateral salpingo-oophorectomy in carriers of pathogenic mismatch repair variants: a Prospective Lynch Syndrome Database report. | Eur J Cancer | 2021 |
| 33792829 | Correction to: Letter to the Editor-Recent advances in Lynch syndrome. | Fam Cancer | 2021 |
| 33589764 | The rise of point-of-care genetics: how the SARS-CoV-2 pandemic will accelerate adoption of genetic testing in the acute setting. | Eur J Hum Genet | 2021 |
| 33608039 | Introduction of an assessment toolkit associated with increased rate of DLB diagnosis. | Alzheimers Res Ther | 2021 |
| 33499123 | How Should We Test for Lynch Syndrome? A Review of Current Guidelines and Future Strategies. | Cancers (Basel) | 2021 |
| 34758253 | 100,000 Genomes Pilot on Rare-Disease Diagnosis in Health Care - Preliminary Report. | N Engl J Med | 2021 |
| 34419788 | Altered network stability in progressive supranuclear palsy. | Neurobiol Aging | 2021 |
| 34043773 | European guidelines from the EHTG and ESCP for Lynch syndrome: an updated third edition of the Mallorca guidelines based on gene and gender. | Br J Surg | 2021 |
| 33991240 | Trajectories of pain over 6 years in early Parkinson's disease: ICICLE-PD. | J Neurol | 2021 |
| 34203177 | No Difference in Penetrance between Truncating and Missense/Aberrant Splicing Pathogenic Variants in <i>MLH1</i> and <i>MSH2</i>: A Prospective Lynch Syndrome Database Study. | J Clin Med | 2021 |
| 34050928 | Sebaceous tumours: a prototypical class of skin tumour for universal germline genetic testing. | Br J Dermatol | 2021 |
| 34024781 | Which Neuropsychological Tests? Predicting Cognitive Decline and Dementia in Parkinson's Disease in the ICICLE-PD Cohort. | J Parkinsons Dis | 2021 |
| 33973693 | Spatial Covariance of Cholinergic Muscarinic M<sub>1</sub> /M<sub>4</sub> Receptors in Parkinson's Disease. | Mov Disord | 2021 |
| 33257847 | Risk-reducing hysterectomy and bilateral salpingo-oophorectomy in female heterozygotes of pathogenic mismatch repair variants: a Prospective Lynch Syndrome Database report. | Genet Med | 2021 |
| 33111402 | Genome-Wide Association Studies of Cognitive and Motor Progression in Parkinson's Disease. | Mov Disord | 2021 |
| 33382126 | Cholinergic Basal Forebrain Volumes Predict Gait Decline in Parkinson's Disease. | Mov Disord | 2021 |
| 32770425 | Letter to the Editor-Recent advances in Lynch syndrome. | Fam Cancer | 2021 |
| 32683684 | The "unnatural" history of colorectal cancer in Lynch syndrome: Lessons from colonoscopy surveillance. | Int J Cancer | 2021 |
| 32571974 | Management strategies for the colonoscopic surveillance of people with Lynch syndrome during the COVID-19 pandemic. | Gut | 2021 |
| 31337882 | Cancer risks by gene, age, and gender in 6350 carriers of pathogenic mismatch repair variants: findings from the Prospective Lynch Syndrome Database. | Genet Med | 2020 |
| 32054791 | Bladder training for urinary tract symptoms in Parkinson disease: A randomized controlled trial. | Neurology | 2020 |
| 31994774 | Identifying delirium in Parkinson disease: A pilot study. | Int J Geriatr Psychiatry | 2020 |
| 31868677 | Senescence and Inflammatory Markers for Predicting Clinical Progression in Parkinson's Disease: The ICICLE-PD Study. | J Parkinsons Dis | 2020 |
| 31860007 | Diagnosis Across the Spectrum of Progressive Supranuclear Palsy and Corticobasal Syndrome. | JAMA Neurol | 2020 |
| 31941726 | Harveian Oration 2019: Prediction and prevention in the genomic era. | Clin Med (Lond) | 2020 |
| 33192470 | Gait Progression Over 6 Years in Parkinson's Disease: Effects of Age, Medication, and Pathology. | Front Aging Neurosci | 2020 |